About Us

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries.

Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.

To date, MPP has signed agreements with 11 patent holders for thirteen HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment and a licence for long-acting technologies.

In 2020, MPP’s mandate was temporarily expanded to include COVID-19 treatments. In 2021 it was expanded further to include the licensing of technology with an initial focus on COVID-19 vaccines and pandemic preparedness. MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC).

Featured

VaxPaL

08 June 2021

COVID-19 Open Pledge

12 November 2020

Kenya

26 October 2020

Ukraine

30 June 2020

MPP in Numbers

0

patent holders with MPP signed agreements

0

generic manufacturers and product developers have sublicences from MPP

0

countries have benefitted from access to MPP-licensed products

0+

ongoing pharmaceutical development projects

0Bn

Billion dollars saved by the international community, from January 2012 to December 2020

0Bn

Billion doses of treatment supplied from January 2012 to December 2020

0Mn

Million patient-years of treatment through MPP’s generic partners, from January 2012 to December 2020

For Everyone Everywhere

Discover where we helped and what we have achieved

 

Patent and licensing status: last updated on 11 May 2021. Disclaimer | Product availability data from MPP sublicensees: last updated in October 2021 (data as of 30 June 2021) | Note: Sales may occur in countries in the absence of registration via procurement channels, registration waivers and/or exemptions

Impact Stories

Key Publications

Contact Us

MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders